 - Patients: Patients with obesity degree I-III, with pCO2 awake and at rest 45 mmHg, with no underlying pulmonary or neuromuscular lung disease; two control groups, one of non-hypoventilating obese patients and the other of obese patients with OSAHS, will also be studied over the same period. 